Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway (Q42510580)

1 November 2017

Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway (English)

1 reference

1 November 2017

0 references

Delhanty PJ

1

1 reference

1 November 2017

van Koetsveld PM

2

1 reference

1 November 2017

Gauna C

3

1 reference

1 November 2017

van de Zande B

4

1 reference

1 November 2017

Vitale G

5

1 reference

1 November 2017

Hofland LJ

6

1 reference

1 November 2017

van der Lely AJ

7

1 reference

1 November 2017

3 April 2007

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 November 2017

1 reference

1 November 2017

293

1 reference

1 November 2017

E302-9

1 reference

1 November 2017

1

1 reference

Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells

1 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

A receptor in pituitary and hypothalamus that functions in growth hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Emerging treatment strategies for adrenocortical carcinoma: a new hope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Circulating ghrelin levels and central ghrelin receptor expression are elevated in response to food deprivation in a seasonal mammal (Phodopus sungorus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00377.2006

10.1152/AJPENDO.00377.2006

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference